Disease Area Strategy

PRESCIENT ADVISORY

Disease Area Strategy

Delivering a compelling vision through upstream cross- functional collaborations

Integrating corporate, product and therapy area strategies is critical to provide a clear strategic direction that bridges science and commerce, ensuring the values of portfolios and brands are maximized. Creating a long-term and integrated vision of the therapeutic area requires effective upstream cross-functional collaboration between the R&D, medical and commercial teams.

RELATED CONTENT